Minglie Hu
Founding Partner, Chairman @ Lighthouse Capital Management
Minglie Hu is a Series C investor at Lighthouse Capital Management focused on Medical and Health Care. Minglie Hu is the Founder and currently works as the CEO for ZHANG YUE YOU XI.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Minglie Hu invests in
Stages Minglie Hu invests in
Countries Minglie Hu invests in
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Medical Device 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
iHear Medical
|
iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearingaid.iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR.iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers.iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies. | $2.6M / Series C / Jan 15, 2016 | |
|
iHear Medical
|
iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearingaid.iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR.iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers.iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies. | $5M / Series C / Nov 24, 2014 |
Co-Investors
Aphelion Capital
2 deals together
About Lighthouse Capital Management
Lighthouse Capital Management is an early venture capital fund focusing on the Chinese and US markets. It has been focusing on angel/VC equity investment in excellent content and products and currently manages two RMB Fund and a dollar fund.The firm has invested in more than 40 growth projects in mainland China and overseas, focusing onhardware equipment and "Internet +" method empowerment and enterprise data services. It is managing billions of dollars in total assets, investing in the total market value of domestic and foreign companies over 100 Billion dollars.Lighthouse Capital was founded in 2011 and is based in Shanghai, China.
Lighthouse Capital Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Danny Qin
Partner
|
|||
|
Minglie Hu
Founding Partner, Chairman
|
|||
Qianqian Yang
Partner
|
|||
Wei Li
Founding Partner, President
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Minglie Hu invest in?
Minglie Hu invests primarily in Medical, Health Care and Medical Device startups, most often at Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Minglie Hu last invest?
The most recent investment recorded for Minglie Hu closed in Jan 2016. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
